A bi-weekly print online publication - featuring: Technology, Financial and Healthcare stocks, Komag Inc. (KOMG-NASDAQ), Old National Bancorp (IN) (ONB-NYSE), First State Bancorporation (FSNM-NASDAQ), Possis Medical, Inc. (POSS-Nasdaq).

wpe3.jpg (15694 bytes)

 CURRENT ISSUECOVER ARCHIVES  |  INDEX  |  CONTACT  |  FINANCIALS |  MARKETING SERVICES | HOME PAGE

  

CEOCFO-Members Login
Become A Member!


wpe1.gif (2113 bytes)


Analyst Interviews 
To view Interviews: highlight & left click on the company name!

August 22, 2008
Financial, Technology, Basic Materials, Healthcare, Alternative Infrastructure, Consumer Goods & Energy

Financial
Regional – Southwest Banks
Analyst Interview Covering: First State Bancorporation (FSNM-NASDAQ)
Peyton N. Green, Senior Analyst, Financial Institutions Group, FTN Midwest Securities Corp.

“First State Bancorporation is buy-rated given a discounted valuation approximating 65% of tangible book value and our belief that the Company will get past its recent credit quality woes and return the franchise to solid profitability and strong EPS growth. Based on our analysis, we believe that the economy in New Mexico will be stronger than most expect. Also, the Colorado economy should outperform the national economy.” - Peyton N. Green




August 8, 2008
Energy, Technology, Services, Mining & Basic Materials

Energy
Oil & Gas Exploration

Analyst Interview Featuring: Highpine Oil & Gas Limited (HPX-TSX)
Kim Page, Director – Energy Research
Wellington West Capital Markets, Inc.

“The area is a massive reef complex containing numerous large light oil and gas pools. The initial discovery in the oil prone portion of the resource trend was approximately 8 years ago, and there have been over 30 new pools discovered since. It was the advent of technology and the refinement of 3D seismic imaging of these Nisku pools that has increased Highpine’s discovery success rate to over 60%.” - Kim Page
 



May 16, 2008
Technology, Financial, Mining, Services, Energy & Healthcare

Energy
Security

Money Manager Interview Covering:
Eurocontrol Technics Inc. (EUO-TSX: V)
James Guiang, Senior Portfolio Manager, Managing Director
Millennium Global Natural Resources Fund

Offering What Could Be An Industry Standard Hydrocarbon Marking Technology For National And International Companies Identifying Their Products Is Giving Eurocontrol Exceptional High-Growth Potential

Financial
Southeast Community Banks

Analyst Interview Covering:
Green Bankshares, Inc. (GRNB-NASDAQ)
P. Carter Bundy, CFA, Vice President
Stifel, Nicolaus & Company

“I’ve given Green Bankshares a ‘buy’ rating, with a $23 target price. People should be looking at the stock because it returns excellent returns on tangible equity. It’s projected this year to do, let’s just say mid-teens about 15% returns on tangible equity and likely to do that out in 2009 and potentially better.” - P. Carter Bundy, CFA



April 4, 2008
Healthcare, Technology, Metals/Mining, Exploration, Aerospace, Distributors, Energy & Services

Retail
Consumer Goods

Analyst Interview covering: Big Lots, Inc. (BIG)
Joan Storms, CFA, Wedbush Morgan Securities

“Big Lots fits nicely into the discount category because it is the largest closeout retailer in the United States. Their core customer is not necessarily the dollar store customer because they can and do charge higher prices as long as it represents a good value to the customer.” - Joan Storms, CFA



November 9, 2007
Services, Exploration, Energy, Airlines, Healthcare, Financial, Communications, CATV Systems & Telecommunications

Healthcare
Drug Development Services

Analyst Interview Covering
PharmaNet Development Group, Inc.(Nasdaq-PDGI)

David Windley, Managing Director
Jefferies & Company, Inc.

‘I think investors should look at Pharmanet as a participant in a very rapidly growing space. One of the factors that I didn’t mention earlier was that in addition to the underlying growth of development spending at about 10 or 11%, an increasing percentage of that spending is being outsourced, so the outsourced industry is growing closer to 15 to 20%. Pharmanet is a participant in that industry growth. Because of their issues in 2006, they have trailed the industry averages and have the opportunity to trend up toward industry averages. They are run by a very seasoned management, with Jeff McMullen and his team, a very large part of which have been with him for years. So from a take-away stand point I would look at Pharmanet as a quality player in a segment of healthcare that is growing very rapidly on an organic basis with some opportunity to improve margins and drive earnings growth faster than revenue growth.” - David Windley



September 14, 2007
Manufacturing, Services, Healthcare, Industrial Goods, Technology, Financial, Exploration, Consumer Goods & Energy

Technology
Analyst Interview Covering
:
Ansoft Corp. (Nasdaq-ANST)
Bradley L. Mook, CFA, Boenning & Scattergood, Inc.

“Right now they are seeing growth from a number of areas. The technology becomes increasingly important as the world continues to move in that direction. Specifically we are seeing it from automotive with the increasing electronic content in cars, in particular hybrids. Consumer electronics companies are using their design tools and there is a lot of strength out of Asia right now for some of the consumer electronics applications. Just last quarter they said that wireless infrastructure equipment is making a bit of a comeback. There are various pockets that are driving the strength now but in general it tends to be broad based.” - Bradley L. Mook, CFA



May 25, 2007
Financial, Consumer Goods, Healthcare & Exploration

Financial
Regional Banks

Analyst Interview Covering:
First State Bancorporation (FSNM-NASDAQ)
Peyton N. Green, Senior Analyst, Financial Institutions Group
FTN Midwest Securities Corp.

“The CEO, Michael R. Stanford, along with COO, H. Patrick Dee, have been with the company since the early days. What is most impressive is that they took a community bank with a strong position in Taos, which is not a growth market, and have created the largest local bank in Albuquerque, after starting basically from scratch. Back in 1994 when they moved into Albuquerque, they had maybe 1% market share, which has blossomed into 14%, positioning First State as the third largest bank in the MSA and the largest local bank. Over 80% of the growth was organic. They went from a position of not even being known to one of being very visible in New Mexico over the last 14 years. At the time, no one gave them much of a chance. Certainly in much of the 1990’s, there was a ton of M&A activity in New Mexico and First State benefited from being stable and in a growth mode.”

“We feel 10% balance sheet growth will look pretty good over the next couple of years, maybe even 3 years. We believe that First State will do better than that given its concentration in the inter-mountain West. Separately, management’s focus on improving bottom-line profitability, should enable earnings per share (“EPS”) to grow 15 to 20% over the next couple of years; coupled with the pullback in the valuation over the past six months, the opportunity for above average top-line and bottom-line revenue and EPS growth makes the shares particularly interesting in our opinion. Again, we believe top line balance sheet growth should be 10%-plus and bottom line growth should approach 15 to 20%.” - Peyton N. Green, Senior Analyst, Financial Institutions Group, FTN Midwest Securities Corp.



February 15, 2007
Healthcare, Exploration, Technology, Industrial Goods Telecommunications & Financial

Healthcare
Biotechnology & Drugs

Analyst Interview Covering: Vical Incorporated (VICL-NASDAQ)
George Fulop MD, Vice President, Biotechnology & Life Sciences
Needham & Co.

“Vical has a unique technology that caught my attention; they used DNA vaccines and address many conditions ranging from HIV to influenza and even avian flu. They have a unique technology that I think is promising and an alternative to traditional vaccine development.” - George Fulop MD



 


ceocfointerviews.com does not purchase or make
recommendation on stocks based on the interviews published.